Covered recipient · General Payments record
ROBERTO D ALVAREZ SWIHART
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$27,952.49
- Reported across 221 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $642.57 | 31 |
| Consulting Fee | $325.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $406.75 | 5 |
| Amgen Inc. | $283.87 | 13 |
| Organon LLC | $104.25 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $60.85 | 3 |
| Acerta Pharma LLC | $39.82 | 2 |
| Eli Lilly Export S.A. Puerto Rico Branch | $25.00 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.36 | 1 |
| PBG PUERTO RICO LLC | $14.50 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $325.00 | 02/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103131383 | CMS |
| ABBVIE INC. | $12.57 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103215711 | CMS |
| ABBVIE INC. | $31.02 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103215713 | CMS |
| ABBVIE INC. | $5.13 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103215715 | CMS |
| ABBVIE INC. | $33.03 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103215717 | CMS |
| Amgen Inc. | $22.46 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422832 | CMS |
| Amgen Inc. | $21.39 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422799 | CMS |
| Amgen Inc. | $20.00 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422818 | CMS |
| Amgen Inc. | $19.52 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422824 | CMS |
| Amgen Inc. | $21.39 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422802 | CMS |
| Amgen Inc. | $23.06 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422807 | CMS |
| Amgen Inc. | $22.73 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422828 | CMS |
| Amgen Inc. | $22.10 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422810 | CMS |
| Amgen Inc. | $22.10 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117493588 | CMS |
| Amgen Inc. | $22.10 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422815 | CMS |
| Amgen Inc. | $22.10 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422792 | CMS |
| Amgen Inc. | $22.46 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422836 | CMS |
| Amgen Inc. | $22.46 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115422795 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.18 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104458694 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.64 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105230137 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.36 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117921931 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.17 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101500542 | CMS |
| Eli Lilly Export S.A. Puerto Rico Branch | $25.00 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135374772 | CMS |
| Novartis Pharmaceuticals Corporation | $19.41 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086686457 | CMS |
| Novartis Pharmaceuticals Corporation | $20.72 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086686475 | CMS |
| Novartis Pharmaceuticals Corporation | $20.72 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086686483 | CMS |
| Organon Llc | $18.89 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136307117 | CMS |
| Organon Llc | $10.99 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136307119 | CMS |
| Organon Llc | $22.47 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136307115 | CMS |
| Organon Llc | $27.65 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136307109 | CMS |
| Organon Llc | $24.25 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136307111 | CMS |
| PBG PUERTO RICO LLC | $14.50 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131605762 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.